A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 gene helps CAR-T cells fight cancer more effectively. These findings could improve immunotherapy for patients with aggressive cancers such as leukemia.
Gene modification could improve cancer treatment’s success rate
